Three Companies Form the MedTech Laser Group

MedTech Laser Group has formed via the acquisition of A.R.C Laser GmbH., a German company based in Nuremberg, and of G.N.S. neoLaser Ltd. an Israeli company based in Caesarea (close to Tel Aviv, Israel), by Afinum 9, advised by Afinum Management GmbH, based in Munich, Germany. International Healthcare M&A advisory firm, MedWorld, acted as advisors in this trasaction. 

 

In this partnership, the founders of A.R.C Laser and neoLaser will jointly invest in the formation of this integrated medical laser technology company. As part of the transaction, Afinum acquires a significant majority stake while the founders re-invest in the newly formed entity.

 

A.R.C. Laser offers an extensive range of innovative laser technologies focused on ophthalmic treatments, particularly for glaucoma and cataract procedures. Leveraging its strong R&D capabilities, A.R.C. Laser has successfully diversified its product portfolio to include surgical applications in Laryngology, Otology, Rhinology, and Veterinary medicine. 

 

Founded in 2012, neoLaser, stands out as a fast-growing specialist in laser systems and fibers for Endovenous Laser Ablation and applications in Proctology. neoLaser has positioned it as a leader in its respective fields, through its advanced laser solutions. 

 

Under the umbrella of the MedTech Laser Group, A.R.C. Laser and neoLaser will be able to jointly capitalize on this market opportunity. This partnership is designed to harness synergies for further topline growth. 

 

Both companies will continue to operate as independent entities while leveraging their combined strengths to collaborate on research and development, sales and marketing, and regulatory matters. The joint growth strategy will emphasize international expansion and an enhanced go-to-market approach. Also, the group will broaden its technology and product portfolio organically and potentially through strategic add-on acquisitions.

 

Afinum is an independent investment firm focusing on small- and medium-sized companies. Afinum focuses on Healthcare, Industrial Technology, Software & TMT, and Consumer & Internet. 

 

This transaction marks the tenth platform investment of the Afinum 9 fund and the third thematic investment in the Medtech sector. 

 

MedWorld Advisors represented the sellers in this transaction as their exclusive advisor and facilitated and managed the transaction.